Charting the Global Landscape—Peter Yu discusses the impact of the credit crisis across Europe, Asia and Latin America, and details how Cartesian mitigates risk

July 2010

Mergers & Acquisitions – The Dealmaker’s Journal

By Ken MacFadyen

Peter Yu’s career path into private equity didn’t follow a traditional route. He never spent time as a consultant and didn’t put in long hours as a junior banker. Before heading to Wall Street, he spent a good portion of his early career in Washington, notably as a law clerk under outgoing Supreme Court Justice John Paul Stevens and then later, during the Clinton administration, as director to the National Economic Council, the White House office that develops and coordinates economic policy.

It’s this background in diplomacy and compromise that prepared Yu for the challenges of buying companies and investing in emerging markets. He is not a proponent, for example, of seeking control as a way to mitigate risks. Rather, he takes the opposite tack, using minority-stake deals to align interests. This kind of “soft power” approach would make most PE investors bristle, especially in countries where the rule of law may not be consistent or entirely clear.


Download the full article as a PDF

here

.

2009—Private Equity’s Most Boring Year. Good Riddance!

December 30, 2009

Erin Griffith

PEhub.com


Peter Yu, Cartesian Capital


What will be different in 2010, for the industry and for your own investment activity?

For us, 2009 was a year of truly extraordinary opportunities: capitalizing on dislocations has always been our focus and 2009 was rich with dislocations.

The yawning gap that has developed between equity markets and economic reality will persist in 2010. (Central-bank-created liquidity is to investment-bank-created liquidity as methadone is to heroin: perhaps less toxic but causing equally severe withdrawal.)

As a result, investment opportunities in 2010—for value and growth-oriented investors at least—will generally be less attractive.


Read the full response from Peter Yu at

PEhub.com

Cartesian’s Contract Research Platform Goes Further Into Asia

December 2, 2009

By Beina Xu

Dow Jones LBO Wire – Healthcare

Looking to further expand globally, Cartesian Capital Group LLC’s pharmaceutical services platform ReSearch Pharmaceutical Services Inc. has deepened its footprint in Asia with the acquisition of Paramax International Inc., a Beijing-based contract research company.

RPS, based in Fort Washington, Pa., paid about $1.9 million in cash and stock for Paramax, according to a Securities and Exchange Commission filing.

Cartesian first invested in RPS at the end of 2007 in a growth equity deal, according to Cartesian Managing Partner Peter Yu. The firm has worked to aggressively expand the company’s global reach, completing deals for contract research organizations in France, Spain and Germany. Paramax is its fourth add-on deal.

The company had significant operations in the U.S. and Latin America, but the firm wanted it to go broader, Yu said.

“Our longer term perspective was that the world’s pharmaceutical companies had to have CRO capabilities in emerging markets,” Yu said. “If you look at the next 10 years of growth for these companies, they have to do few things at same time: increase their research development work, identifying new compounds, grow aggressively in emerging markets, and keep fixed costs in control. Those are all factors that favor growth for RPS.”

For the three months ended Sept. 30, RPS pulled in $57.3 million in revenue, compared with the $44 million for the year-earlier quarter. Net income rose to $994,033 from $748,239. The company was listed on the Alternative Investment Market of the London Stock Exchange until September.

RPS is a portfolio company of Pangaea One, which closed in 2006 at $1 billion.

RPS Chief Executive Dan Perlman was not immediately available to comment.

Reach Cartesian Capital at 212-461-6363.

Home



http://www.rpsweb.com

Five Questions With… Peter Yu, Managing Partner & Founder, Cartesian Capital Group

November 16, 2009

Buyouts Beat


Cartesian Capital Group is known for private equity investing in the aftermath of crises. Are you seeing opportunities now?

We do seek pricing inefficiency in dislocations. We were very active in Asia following the 1997 crisis, in Russia after the ruble devaluation, in the airline industry after the tragedies of 9/11, in telecoms following the 2001 bubble and in Latin America in 2003. Consistent with this strategy, in this past year we made investments in financial services, in the automotive sector, and in dry bulk shipping—all sectors suffering notable dislocations.


Read the full article at

www.buyoutsnews.com/story.asp?storycode=48827

In Emerging Markets, Investing Still Comes At A Price

September 18, 2009

By Beina Xu

Dow Jones

As much as emerging markets have been the tortoise in the race to rebound from the recession, investors in the sector still have to tread carefully about what they invest in, and where.

Markets like India and China have come back with relative resilience; capital markets in both countries have shown upside with increased IPO sightings. But many risk profiles still remain challenging for investors to grapple with, including pricing, regulation, corruption worries, and as always, cultural differences, according to a panel at the Dow Jones Private Equity Analyst Conference in New York on Thursday.

“It pays to be highly selective in emerging markets,” said Jonathon Bond, a partner with London-based Actis.

But it also pays to be an emerging market company. Pricing has become increasingly competitive – a premium that many private equity investors seem more willing to pay for entry into the market. Bond cited a deal Actis closed in Egypt for a 10% stake in a top bank for which it paid a little over two times book value.

“Most thoughtful investors are beginning to say that since it’s about growth, perhaps it’s appropriate to pay higher prices for smaller returns,” he said, although Shailesh Dash, managing partner at Global Capital Management, said not all emerging markets were necessarily trading at that level.

What investors need to look for is inefficiencies in pricing, rather than chasing the efficiencies, according to Cartesian Capital Group’s Peter Yu. The firm had funded an airline after 9-11, bought assets from Enron and Worldcom and most recently purchased shares in Citibank.

And the best niches are still the most expensive. Bond said his firm “still likes the Chinese consumer story,” as well as the Indian consumer market, but that both were very fully priced. North Africa and Brazil were also selectively attractive.

“Now we’re trying to recognize that we’re living in a world of permanently higher pricing,” Bond said. “Although the heat map may guide you on the macro level, it’s now down to the GP to really build on sector expertise, location expertise. The growth is there, it’s just about what price you’re getting to pay to get on the escalator.”

Overall, minority investments are the preferred path for myriad reasons, most notably regulation and cultural gaps, according to panelists. Out of the past 70 deals Actis has done in the last 10 years, around two-thirds have been minority, according to Bond. Yu said Cartesian has always preferred minority control with 40% to 45% ownership and a “strong alignment in interest” with the company.

“Soft power in emerging markets in PE is the preferred path,” he said. But for Dash, soft power can only go so far in countries where regulation makes leveraged buyouts nearly impossible.

Being slow helps. Cartesian has a “gestation” period per deal of around 11 months, which it spends building relationships with sellers that oftentimes back out by month three, Yu said.

“In some ways the phrase ’emerging markets’ is a little out of date,” Yu said. “There’s no one who’d rather land in JFK Terminal Three than Beijing Terminal One. The world has globalized – and the companies we select will be based on whether they’re globally competitive.”